Core Viewpoint - The company is experiencing a positive operational trend, with stable domestic business and strong growth in overseas markets, alongside potential profit improvements due to declining raw material costs and the expansion of new business segments [1][3]. Sales Performance - Domestic demand for yeast and its derivatives remains stable, with inventory reduction efforts showing initial success in Q1 2025. Revenue from domestic operations improved sequentially in Q2 2025, continuing into Q3 2025 [1]. - Overseas revenue grew significantly in H1 2025, with a year-on-year increase of 22.6%. The demand for dry yeast products in developing countries remains strong, and the company's subsidiary in Egypt is performing well [1][2]. Profitability - The company anticipates a more than 10% year-on-year decline in comprehensive costs for 2025 due to lower molasses prices. Stable pricing competition and reduced shipping costs are expected to enhance profitability [2][3]. - The company’s production capacity utilization in overseas factories is high, and ongoing expansion is expected to further release economies of scale [2]. New Business Development - The company is actively developing new business segments such as yeast protein, which has broad applications in beverages, meat products, and snacks. The focus is on market development and capacity building [2][3]. - A project to establish a bio-manufacturing center was announced on June 27, 2025, aimed at enhancing the company's innovation capabilities in biological manufacturing [2]. Outlook - The company is optimistic about maintaining stable domestic demand and continued growth in overseas markets, with new business segments expected to contribute to revenue growth. The anticipated decline in molasses costs and shipping fees is expected to accelerate profit potential [3]. - Future capacity planning will focus on meeting overseas market demand, with the Indonesian factory expected to commence operations in the second half of 2026 [3]. Profit Forecast and Valuation - The company forecasts net profits of 1.66 billion, 1.94 billion, and 2.21 billion yuan for 2025-2027, representing year-on-year growth of 25.0%, 17.3%, and 13.9% respectively. Corresponding EPS is projected at 1.91, 2.24, and 2.55 yuan [4]. - A target price of 45.75 yuan is maintained, based on a 24x PE ratio for 2025, reflecting confidence in the company's growth trajectory [4].